post-exposure prophylaxis

US FDA Clears Shionogi’s Oral Drug Xocova to Prevent COVID-19 After Exposure

Japan’s Shionogi & Co has received approval from the U.S. Food and Drug Administration (FDA) for its oral antiviral Ensitrelvir,…